The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...